DIP Episode 367 - The Clutch Amyloidosis Podcast (for Step 1-3)
Topic
Amyloidosis types (AL, AA, ATTR, _2M); Amyloid deposition in organs (Kidney, Heart, CNS); Diagnostic methods (Congo Red stain; Scintigraphy).
Key Takeaway
Amyloidosis is the pathological accumulation of misfolded proteins that can deposit in multiple organs—most commonly the kidneys and heart—and its specific type depends on the underlying precursor protein (e.g., light chains for AL, Serum Amyloid A for AA, Transthyretin for ATTR).
Episode Notes
Source / episode info
- Episode: 367
- Title: Divine Intervention Episode 367 – The Clutch Amyloidosis Podcast (for Step 1-3)
- Published: 2022-02-04
- Source: Episode page
One-liner
Episode 367 provides a comprehensive review of amyloidosis, detailing the mechanisms and clinical presentations of primary (AL), secondary (AA), transthyretin (ATTR), _2-microglobulin, and amylin-related types across multiple organ systems including the heart, kidneys, and central nervous system.
High-yield summary
- Definition: Amyloidosis is characterized by the extracellular deposition of misfolded proteins that aggregate into insoluble fibrils with a characteristic "pleated sheet" secondary structure.
- Diagnostic Hallmark: Biopsy staining with Congo Red under polarized light reveals apple green birefringence, confirming amyloid deposits.
- Primary vs Secondary Types: Primary AL amyloidosis is associated with Multiple Myeloma (light chains); Secondary AA amyloidosis results from chronic inflammation/infection (Serum Amyloid A).
- Organ Involvement: While the kidney is the most commonly affected organ, cardiac involvement (leading to heart failure and arrhythmias) is often the cause of death.
- Specific Syndromes: Down Syndrome ({T}21 gene product) causes amyloid deposition leading to vascular fragility and hemorrhagic risk; Chronic Kidney Disease/Dialysis leads to _2-microglobulin amyloidosis.
Learning objectives
- Differentiate between the primary (AL) and secondary (AA) causes of systemic amyloidosis based on the precursor protein.
- Recognize the clinical manifestations of specific types of amyloidosis, including cardiac conduction defects, nephropathy, and neurological syndromes.
- Identify the diagnostic gold standard for amyloid deposits using Congo Red stain and polarized light microscopy.
- Understand the unique associations between genetic disorders (e.g., Down Syndrome) or chronic conditions (e.g., CKD/T2 DM) and amyloid deposition.
- Correlate specific proteins (\text{PrP}^{\text{Sc}}, TTR, \beta_2 M, Amylin) with their respective associated diseases.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Amyloidosis | Apple green birefringence (Congo Red stain) | Misfolded protein aggregation; Pleated sheet structure | Always remember the diagnostic staining method and its specific color/light. |
| AL Amyloidosis | Monoclonal light chains ( or ) | Multiple Myeloma, Plasma Cell Dyscrasia | The cause is a plasma cell product (M-spike); think of MM complications. |
| ATTR Amyloidosis | Bradycardia/Restrictive Cardiomyopathy | Elderly male, Chronic Kidney Disease, TTR protein | Think "Old Man + Heart Failure + Low HR" = ATTR. Diagnosis often requires Tc-99m scintigraphy. |
| {PrP}^{{Sc}} (Prion) | Spongiform encephalopathy; Myoclonus | Creutzfeldt-Jakob Disease (CJD) | The protein is misfolded, not a genetic mutation; remember the rapid progression and spongiform appearance. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Amyloid Structure | Pleated sheet secondary structure | All amyloid deposits | Structural knowledge helps differentiate it from other protein aggregates (e.g., neurofibrillary tangles). |
| AL Amyloidosis | Light chain deposition ( or ) | Multiple Myeloma, Plasma Cell Dyscrasia | The cause is the plasma cell itself; remember the CRAB criteria associated with MM. |
| ATTR Amyloidosis | Transthyretin (TTR) protein | Elderly male, Heart failure, CKD | This is a common and critical differential diagnosis for cardiac amyloidosis. |
| _2-Microglobulin | Protein accumulation | Chronic Kidney Disease/Dialysis | Failure to clear this small protein during dialysis leads to deposition; key association with renal failure management. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| An elderly male patient with heart failure symptoms, bradycardia, and a history of chronic kidney disease. | Senile Systemic Amyloidosis (ATTR) | ATTR is the most common type; TTR deposits in the myocardium, causing restrictive cardiomyopathy and conduction defects (bradycardia). Diagnosis often involves Tc-99m scintigraphy. |
| A patient with Multiple Myeloma presenting with unexplained renal failure and recurrent infections. | AL Amyloidosis | AL amyloidosis is caused by monoclonal light chains ( or ) produced by plasma cell dyscrasia, leading to systemic deposition. The classic triad of MM (CRAB) plus amyloid deposits is key. |
| A patient with Down Syndrome who suffers a spontaneous gastrointestinal hemorrhage. | Amyloid Angiopathy | Chromosome 21 ({T}21) contains the precursor protein for -amyloid, leading to excessive deposition in blood vessel walls, causing fragility and rupture risk. |
| A patient presenting with rapidly progressive dementia, myoclonus, and spongiform changes on biopsy. | Creutzfeldt-Jakob Disease (CJD) | CJD is a prion disease caused by misfolded {PrP}^{{Sc}}, leading to spongiform encephalopathy; the pathology description is key. |
| A patient with chronic inflammatory arthritis who develops nephrotic syndrome and cardiac involvement. | AA Amyloidosis | Chronic inflammation (e.g., Rheumatoid Arthritis, chronic osteomyelitis) leads to excessive production of Serum Amyloid A (SAA), which deposits systemically. |
| An old man on hemodialysis presenting with signs of uremic syndrome and enlarged tongue. | _2-Microglobulin Amyloidosis | _2-microglobulin is normally cleared by the kidneys; failure to clear it during dialysis leads to its accumulation and amyloid deposition. |
Differential diagnosis / distinguishing features
Systemic Amyloidosis Types
| Key Features | Distinguishing Findings | Next Step |
| AL Amyloidosis | Associated with Multiple Myeloma; deposits are monoclonal light chains. | Serum protein electrophoresis/Immunofixation Electrophoresis (SPEP/IFE) to identify M-spike. |
| AA Amyloidosis | Associated with chronic inflammation (RA, infection); deposits are polyclonal SAA. | Identify the underlying source of chronic inflammation (e.g., RA workup). |
| ATTR Amyloidosis | Deposits TTR protein; often affects heart/kidneys in elderly males. | Measure serum TTR levels and perform Tc-99m scintigraphy. |
| _2-Microglobulin Amyloidosis | Associated with chronic renal failure/dialysis. | Assess degree of kidney function impairment (eGFR, proteinuria). |
Neurodegenerative Proteinopathies
| Key Features | Distinguishing Findings | Next Step |
| Prion Disease ({PrP}^{{Sc}}) | Rapidly progressive dementia, myoclonus, spongiform changes. | EEG/MRI findings (e.g., restricted diffusion); CSF analysis; ruling out other causes of encephalopathy. |
| -Amyloid Plaques | Associated with Down Syndrome ({T}21 gene product). | Genetic testing for {T}21; vascular imaging to assess vessel fragility. |
| Tau Protein/Amylin | Deposits in neurons; associated with specific dementias (e.g., AD, T2 DM). | Clinical correlation and exclusion of other metabolic causes of dementia. |
Management pearls
- Diagnosis: The definitive diagnosis requires identifying the precursor protein type (light chains, SAA, TTR, etc.) via biopsy or specialized testing, not just seeing amyloid deposits.
- Cardiac Amyloid Workup: In any patient with unexplained restrictive cardiomyopathy and conduction defects, perform a Tc-99m scintigraphy to screen for ATTR deposition.
- Multiple Myeloma Screening: Always check for signs of AL amyloidosis (renal failure, neuropathy) in patients with plasma cell dyscrasia.
- Down Syndrome Management: Aggressive monitoring for vascular complications and hemorrhage risk is crucial due to \text{T}21 gene product deposition.
Don't miss
Integration & clinical reasoning
- Renal Failure & Amyloidosis: Chronic kidney disease predisposes patients to amyloidosis via multiple mechanisms: accumulation of \beta_2-microglobulin, secondary hyperparathyroidism (calciphylaxis), and uremia itself.
- Endocrine/Metabolic Links: Type 2 Diabetes Mellitus leads to insulin resistance, causing the accumulation of amylin (an islet amyloid polypeptide) which deposits in the pancreas, contributing to \beta-cell burnout.
- Genetic Predisposition: The presence of a trisomy (e.g., Down Syndrome/Trisomy 21) provides an excess source of precursor protein (\text{T}21 gene product), leading to systemic amyloid deposition and vascular complications.
Concept connections / cross-references
- For general renal tubular physiology, see the notes on [Renal Tubular Acidosis].
- For understanding plasma cell dyscrasias and bone marrow pathology, review [Multiple Myeloma/Plasma Cell Disorders].
- For prion diseases and neurodegenerative disorders, consult [Neurodegeneration Basics].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| AL Amyloidosis | Multiple Myeloma (MM) | Deposition of monoclonal light chains ( or ) from plasma cells. | Leads to nephrotic syndrome, neuropathy, and restrictive cardiomyopathy; requires plasmapheresis/chemotherapy. |
| ATTR Amyloidosis | Transthyretin (TTR) protein | TTR misfolding and deposition in the myocardium. | Classic presentation is heart failure with severe bradycardia; diagnosis confirmed by Tc-99m scintigraphy. |
| _2-Microglobulin Amyloidosis | Chronic Kidney Disease/Dialysis | Failure to clear _2-microglobulin via renal filtration. | High risk in patients on long-term dialysis; requires careful management of uremic toxins. |
| Amylin Deposition | Type 2 Diabetes Mellitus (T2 DM) | Accumulation of amylin peptide due to severe insulin resistance/hyperinsulinemia. | Contributes to pancreatic -cell failure and is a key metabolic complication to monitor. |
Key terms glossary
| Term | Definition | Context | Example |
| Amyloidosis | Extracellular deposition of misfolded, insoluble protein fibrils with a characteristic pleated sheet structure. | Pathology/Systemic Disease | AL amyloidosis (from MM) or ATTR amyloidosis (from TTR). |
| Congo Red Stain | A histological stain used to visualize amyloid deposits. | Diagnostic Tool | Positive result is apple green birefringence under polarized light. |
| {PrP}^{{Sc}} | Pathogenic, misfolded form of the normal prion protein ({PrP}^C). | Prion Diseases (e.g., CJD) | Causes spongiform encephalopathy; transmitted via contaminated tissue/instruments. |
| Transthyretin (TTR) | A serum transport protein that can misfold and deposit amyloid fibrils. | ATTR Amyloidosis | The most common cause of systemic cardiac amyloidosis in the elderly male. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Amyloid Classification | Create a flow chart: Clinical Presentation -> Most Likely Protein -> Underlying Cause. | High (Board-level differential) | Review board vignettes linking symptoms to specific protein types (AL, ATTR). |
| Diagnostic Workup | Memorize the key diagnostic tests and their interpretations (e.g., Congo Red stain, Tc-99m scan). | Medium-High (Must know the "how") | Practice interpreting biopsy slides/scintigraphy results. |
| Complications | Link amyloid deposition to specific organ failure (Heart -> Bradycardia; Kidney -> Nephrotic Syndrome). | High (Clinical correlation) | Focus on the most common cause of death for each type (e.g., Heart failure in ATTR). |
Question pattern recognition
- Pattern: Elderly Male + Restrictive Cardiomyopathy + Bradycardia: Strongly suggests ATTR Amyloidosis . Next step is Tc-99m scintigraphy and TTR testing.
- Pattern: Multiple Myeloma/Plasma Cell Dyscrasia + Renal Failure: Highly suspicious for AL Amyloidosis . Confirm with SPEP/IFE to find the M-spike (light chain).
- Pattern: Dementia + Myoclonus + Spongiform changes: Classic presentation of a Prion Disease (\text{PrP}^{\text{Sc}}), most commonly CJD.
Test yourself
Common mistakes to avoid
Common traps
Original transcript with highlights
Original transcript with highlights
Okay, welcome. My name is Divine. This is episode 367 of the Divine Intervention podcasts and this podcast I'm going to be tightly in this as the Clotch Milloydosis Podcast. The Clotch Milloydosis Podcast. I'm a lot is a very high-ealtopic and before I jump right into it if you're taking your USMELY step two, CKO step three or complex level two or three exams within this month or I will see within the first three weeks of March. Then I do have an MBME Testikin Strategy's course, Tikin Place on the 21st from to the 430 PM Mountain Time which is photo 630 Eastern, basically two hours behind Eastern Time and then I have a 24 hour review course. It's going to be Tikin Place from the 22nd to the 25th of February and all of this is Thruzum. The 24 hour courses from 70 to 1 PM Mountain Time. That's like 9 to 3 PM Eastern Time every day. So if you're interested just shoot me an email through the website and I'll give you some more information. Again, I've had many people take the course and they've done extremely well on the exams. In fact, I got I've got in many emails from people that I've got in the 260's, the 270's and even the red 280's from taking my course. So again, I think it's something you're going to find to be helpful and then if you're taking your USMELY exams in the summer I have a Divine Intervention Step 2 CK School. It's going to be taking place within the first two weeks of May. It's going to be a 70, basically it's going to be 75 hours.
We're going to have like an expanded Tikin Strategy course. We're going to have adaptive learning. We're going to have like a ton of review. In fact, I would imagine that by the end of the course, the school, people should have about 400 to very likely 500 or more pages of notes. That does not include the slides, the tons and tons of slides they would have as well. So again, if you're interested, just shoot me an email through the website. I have a pretty comprehensive podcast where I talked about it's a colleague at the disk DISK school. Okay, so let's jump right into Ameloidosis. So this should be a short podcast. So what is Ameloid? Well, Ameloid is just pretty much a mis-forted protein. Ameloid for the most part is a mis-forted protein and you know, there are two ways you can get Ameloidosis. I will say probably the most common pathway is you start with a protein that is normal, but because your body just produces so much of it, so much of it, it then accumulates and begins to cause problems. Right? Or it can also be a protein that your body accumulates because you can not just get rid of it, right? Again, just think about it, right? Like if for example, something just keeps accumulating, accumulating, accumulating. Over time, it's going to become problematic. Your body does not like things like accumulating. That's why your body has many organs to help you get rid of stuff like your GI tract, your kidneys, your liver, right? Even your skin is an excretory organ, right?
But if all these things are accumulating with nowhere to go, then that becomes a problem. And we'll talk about some of these things really like if you understand what we talk about here today, it should be able to answer pretty much all your Ameloidosis questions, right? On the exam, right? And then another thing I want to mention is you can also get Ameloidosis from mutations in proteins that then causes them to fall in very weird ways, right? So again, it just kind of depends on, but that one is a lot rarer than just the regular Ameloid, right? And for purposes of USML exams, sometimes Ameloid is broken down into two parts, right? So we have the primary or E-E Ameloid. Sorry, the primary of the EL Ameloid. So primary or EL Ameloid. That's the one associated with multiple myeloma. And then we have the secondary or E-E Ameloid. That's the one that's associated with pretty much every other cause, right? Especially when you have like chronic infection or chronic inflammation in the body like rheumatoid arthritis, for example, right? Now some structural information that you need to know, this is probably more so for step one, but I want this podcast to be something that will help everyone taking step one through step three and their encounter in Ameloid questions. But a structural thing that's helpful to know about Ameloid is that Ameloid shows up as a bit of pleated sheet, right? Remember, bit of pleated sheets represent a special kind of protein structure.
More specifically, it's a secondary kind of protein structure, right? So it shows up as a bit of pleated sheet, especially when you look at it under an electron microscope. And then it's also high yield to know how to identify Ameloid. When a person has Ameloid doses and you take the Ameloid protein, the thing that's going to happen is if you look at it under, if you're stingy with a particular sting called congruared, and then you look at it on that polarized light, right? You're going to observe apple green by refringents, right? Again, these are just all basic things you kind of want to make sure you know about Ameloid, right? So now let's jump into just almost call it like vignettes that our friends at the NV Me scan can bring, right? So if they give you a question about a person that you know has a history of Down Syndrome that dies of a sub-rock noise hemorrhage. What's going on there? Well, I hope you're thinking about like Ameloid and Geopathy, right? Ameloid and Geopathy. We remember people that have Down Syndrome, right? That's tricellumy 21. They literally have three copies of chromosome 21. And on chromosome 21, we have Ameloid precursor protein, right? So normally if you think about it, if you're normally getting gene product from two chromosomes, but now you're getting from three, you're potentially making excess, right?
Those literally, those beta Ameloid plaques from Ameloid precursor protein, they're going to build up and they're going to deposit in the brain and they're going to cause Alzheimer's, right? Most people that have Down Syndrome right around the age of 40, almost all of them as a rural university have Alzheimer's, right? But again, unfortunately that beta Ameloid are protein can deposit in the walls of blood vessels and make them weaker. When you deposit those things, then those vessels can blow out and the person getting to get into trouble with a sub-rock noise hemorrhage, right? And I guess one thing I should have maybe said in the introduction is Ameloid can affect many organs in the body. But the primary organ, Ameloid loves to go after, is the kidneys. The kidneys are the most commonly affected organ in an ameloidosis. But if you see a person that has ameloidosis die, most times they die from heart disease, right? Ameloidosis can cause the astolic dysfunction of the heart because it can deposit in the walls of the heart, causes like electrical problems in the heart, causes problems with the heart failure appropriately. So the person goes into the astolic heart failure. That is if I'm not mistaken, the most common cause of death in people that have ameloidosis, right? Or if they give you a question about a person, you know, like an old guy that has been having multiple faults, that's a pretty classic way they like to present this, right?
And they may tell you that, you know, he has these, he has these visual hallucinations. Then I really hope you're then about Louis body dementia, right? Remember, Louis body dementia is kind of related to Parkinson's disease, right? So really like these Parkinson's disease, slash Parkinson's disease related syndrome, like multiple systematrophy, for example, they are associated with mutations in a protein with ameloid, right? From a protein called alpha-synuclein. Alpha-synuclein is the protein that causes the problem, right? Or you can see people that have, you know, they give you a question about like a neuropathologist or a person that's an archaeologist and the person over like six weeks, they have this rapidly progressive dementia and then the pass away, right? I would really hope you're saying, oh, divine, and many things they'll have myoclonus, right? That's kertsfold eacop disease, right? kertsfeld eacop disease that's spelled as C-R-E-U-T-Z-F-E-L-D-T, right? kertsfeld eacop, eacop, some people say J-A-C-O-B-O-J-A-K-O-B, right? So kertsfeld eacop disease, it's a pre-on disease, right? Sometimes they call it a spongy form and say phallopathy, one exact, right? So again, remember our friends at the MBA meetings, one thing they've started doing in recent times is instead of using the name that you're used to, they just use a name that describes the pathology. Again, that's why you can not just onkey a little success on this example.
You should onkey, but yet, my wrong, onkey is amazing. It's one of the best tools ever invented, but you need to make sure you're understanding those things, you're just onkey, right? So when a person has kertsfold eacop disease, sometimes they can call it a spongy form and say phallopathy. It's just a description of how the brain looks grossly when those people die, because those people are invariably going to die, right? I remember the protein that causes the problem is the PRP superscript SC protein, right? So PRP superscript SC protein is a pre-on disease, right? It's a pre-on disease. And then if they give you a question about a person that has dementia, has all these inappropriate words, gestures, stuff like that, you want to think about like front to temporal dementia, right? Or even pix disease, sometimes they call it pix disease, right? Those things are actually associated with aminoidosis, right? Really many dementia are associated with aminoidosis, right? So like the protein varies, right? Like it's a tau protein, right? It's a protein that's associated with micro tubules. Remember, micro tubules are things that move along, they're very important for moving neurotransmitters in neurons, right? So it would make sense that it can cause a lot of neurologic disease, because guess what? Your brain is chock full of neurons, right? Even if they give you a question about a computer scientist, right?
That has, is like in his 40s, and you know, he has these choriform movements in appropriate words, right? That's going to be haunting tense, right? Or those are more dominant disease, chromosome 4 problems, C, G, trinoclothid repeats, right? Those are all associated with aminoid, right? Like really like the haunting protein can form aminoid, the haunting protein can form aminoid, right? And then if you give you a question about some old person with pathologic fractures, right? And you notice that the person's causing is like 15, like you know, some crazy high number, the person keeps getting these recurrent infections, right? That's going to be multiple myeloma, right? It's going to be pretty classic for primary or E L analog. Remember, it's a light chains that cause the problem, right? It's a light chains that cause the problem. Remember, in multiple myeloma, right? The homerca, those crop symptoms hypercalcemia, redophilia, anemia, bone pain, right? Again, because again, those plasma cells, they take over the bone marrow, so you're not able to produce red blood cells, so you get an anemia, right? And then you wonder why they're getting recurrent infections. Well, the thing is plasma cells are supposed to be antibody factories, but those plasma cells in multiple myeloma, those cells are super defective, they don't really work well at all, right? So the person is not going to have a good time, right? So they're going to have an annoying dosage, right?
Because those light chains are going to accumulate, right? So that's something that's pretty high to know for, for example, right? And then really if you have any chronic inflammatory state, rheumatoid arthritis, or like a chronic infection, like chronic osteomyelitis, for example, right? Your form and acute phase reactant, that of acute phase reactant is called a serum aminoid A, that serum aminoid A can literally accumulate again and form aminoid, right? Now, what if they give you a question about an old guy, right? Usually, I mean, this condition I'm going to discuss now is certainly happens in old women, but it's something that almost exclusively on NBM Es and also just in the real world happens in old men, right? They give you a question about an old man and he incidiously develops these heart failure symptoms, you know, like he has like pulmonary dima, has druglavenous distension, has low extremity of dima, right? And then they tell you that the money is pretty cardic, right? That's a very specific signature. It's going to be an old man. Usually it's going to be a person over the age of 80 on exam. Sometimes they can give you in the 70s, but usually it's going to be a person over the age of 80, right? Old man with heart failure symptoms and Brady Cardia. If you see this, I really want you to think about something that we call senile systemic amyloidosis, right? Senile systemic amyloidosis, right?
The thing is it's a normal protein, it's a protein called a transphyritin, T-R-E-N-S, T-H-Y, R-E-T-I-N, right? Transphyritin. It can deposit in the heart, right? And again, when amyloid deposits, right? Cosy electrical problems, so you can get all these heart blocks, right? You can get really bad Brady Cardia, right? But they also have heart failure symptoms. That's the classic way. This is one of those things that you learn by a world of high-yod history on inbinding exams, right? And how do you diagnose this senile amyloidosis? So back in the day, and actually to this day, some people still do biopsies, right? Again, biopsie, the heart, you do an endomyocardiobyopsy, guided by echocardiography, usually like a T-E-E, and you get a sample, check it under, you know, polarized light stink on regret, right? You're going to see a blue-green buyer of fringes. I've actually, I think, a moment's taking I've seen this in the real world, but actually, it's not like I think I have seen this in the real world, right? But these days, the way it's diagnosed, you can actually use a nucleobaticine study, right? So there's this thing called the Technician 99 Empire of Forsyth's Gun, right? So Technician 99 M-Synthigraphy, you can use that to diagnose senile systemic amyloidosis, right? Or if they give you a question about a person that has been on dialysis for a long time, right?
And then you start noticing that they have like a couple tonal syndrome, they're having their stolic-cardia dysfunction, they're having like an enlarged tongue. When you see stuff like that, I want you to think about dialysis-related amyloidosis, right? Remember, in dialysis, normally your kidneys can get rid of the protein beta-2 microglobulin, but when you have dialysis, you cannot, right? The dialysis machine cannot get rid of beta-2 microglobulin. So beta-2 microglobulin, right, is one of the things you find on receptors. In many of your immune system cells, it's going to be old up, right? And it's going to form amyloid. Then also remember, for a person who has diabetes, right? Especially with type 2 diabetes, over time, because if you've probably learned this that open a half-type 2 diabetes, you know, over time the aparkis is going to burn out. One of the thoughts as to why the aparkis burns out is because they're making a ton of amyloid, right? That amyloid then deposits in the pancreas and destroys it. So where does that amyloid come from? Well remember, whenever people that have type 2 diabetes, the problem is they have like insulin resistance, right? So people that have type 2 diabetes actually have pretty crazy high amounts of insulin, right? So the thing is, insulin is being made. There's an opportunity that's made at the same time called amylin, AMY, like Amy, right? AMY, LIN, right? Sometimes they call it IEPP, right?
So that amylin can accumulate and form amyloid, right? In fact, you can also see a similar amyloidosis in the presence of an insulin normal. Remember, both are having insulin normal, they're going to have with post-triad, right? It's one of the most obvious trials in all of medicine, right? They're going to be hypogeolicymic, then they're going to have signs of hypogeolicymia, and then said hypogeolicymia will resolve and give them glucose, kind of makes sense. I don't know why that's a tried in the first place, but anyhow, I'm going to get off my soup box, right? So that's another thing that can cause amyloidosis, right? That amylin can form polymers that can then become amyloid, right? Or you see a person that has like an egg mass, right? And again, is that having these antisydents of amyloidosis, like capotono syndrome? Remember, amyloid lost to the positive in the capoton in the capotono, right? And it can cause capotono syndrome, right? It can cause enlargement of the tongue, it can cause cardiac arrhythmias, right? That's not like this function, but again, I said the most one organising involves is the kidneys, right? Those people can absolutely form amyloid, right? So remember, in medallary thyroid cancer, right? Calsytunin, that calcium tonin can, you know, come together and form amyloid, right? So again, those are just all things you want to keep at the back of your mind, for example.
Or you can even give you a question about a person that develops amyloidosis, like this one is not systemic, it tends to be like localized, like it's an injection site's problem, right? Like I mentioned, it has been on chronic injections for HIV, right? This is going to be the drug and fulver type, right? For those of you studying for step one, I'll really hope you know what fulver type is or does, right? It's a fusion inhibitor, right? Remember, GP41 is a protein that enables HIV to fuse and then infect itself, right? So the thing is, fulver tide spelled as ENFU, VIRTID, ENFU Lver tide, right? It can form amyloidosis, right? At the site of injection, right? That's something to just keep in mind, for example. It's just one of these weird things, you see all your exams and you're like, whoa, where did this come from? Right? So again, if you know these things that have described about amyloidosis, you should be in pretty, pretty good shape. So I think I'm going to go ahead and wrap up here. Again, as I do at the end of every podcast, I don't for one or one two day from all the USML exams, step one, step two, CK step three, preclinical medical exams, 30-ish-off exams, and I also offer tutoring for, you know, I offer these courses for step two, CK and step three, right? I have the divine intervention step two, CK school. It's limited to 40 people, again, it's taking place in the first weeks of May. But then I also have 24-hour review course that I host.
That's going to be taking place at the end of this month, again, from the 22nd to the 25th, and an MBME test thinking strategy course on the 21st. And then I do have these podcasts on Apple podcasts, Google podcasts, Spotify, right? So if you're interested in any of these podcasts, just go ahead and find it, you know, you're going to find the most recent 150. If you're on everything from a episode one to episode 367, you have to go on the website, the vinytravensionpodcast.com. If you have a Word Press account and you subscribe, then you get an email notification whenever I make a new podcast. And then I have a You Tube channel, the vinytravension, you have some really podcasts and videos. That's where I post the videos that I make. And I do make quite a few videos every now and then. And then finally, I also have a new website called the vinytravension, lifelessens.com. It's a Bible Bee's website. It's a lot of podcasts and most of them are about 10 minutes long, 10, 12 minutes long. And I just describe a classic problem that's facing humanity. And then just describe how the Bible tacos that problem. I actually also have the podcasts on Apple podcasts, called the Divine Intervention, Lifelessens Podcast. So thank you for listening to me. One quick thing I just want to say here is this is a new year, right? Stop looking backwards, right? Stop looking forwards. I feel like that's kind of like a good life lesson for today, right?
Many people, they just keep looking backwards, keep looking backwards. The thing is, you know, you may have meetings fixing your past. Everyone has meetings at some point. You know, meetings fixing your past, checkered past, you know, bad relationships, bad things you've done, people you've heard, right? But again, you can turn your life around, right? The way you turn around, right? Think about it if you're, if you want to turn around, you should stop moving in the direction we're moving before, right? So if you're moving backwards before, just start moving forwards, right? Start looking forwards. I like this Bible character like a lot. He's wife, you know, they were being delivered from Suttaman Gomorrah, but they were like, a lot of wife was like, you know, what I really like Suttaman Gomorrah a lot, right? They should keep looking at Suttaman Gomorrah and then in the end, she trying to appeal off salt, right? No, just keep moving forward, keep moving forward, right? So I'm telling you, if you've messed up in the past, the fact that you have a bad background, it doesn't, again, you've heard this statement many times, right? Your bad ground should not keep your back to the ground, right? Just keep looking forward, keep pressing forward, right? And all be well with you. So thank you for listening to this podcast. Have a wonderful rest of your day. God bless you and have a great weekend. Thank you.
Practice questions — USMLE style
Question 1 — Pathology/Hematology
A 72-year-old man with a history of multiple myeloma presents to the emergency department after developing severe anemia, bone pain, and signs of renal impairment. Laboratory studies reveal an elevated serum free light chain ratio. Biopsy of the kidney shows amyloid deposition in the mesangium. The most likely protein responsible for this specific form of amyloidosis is:
- A) Beta-2 microglobulin
- B) Serum Amyloid A (SAA)
- C) Light chains (e.g., kappa or lambda)
- D) Transthyretin (TTR)
Answer: C. Primary AL amyloidosis is associated with the deposition of monoclonal light chains (either kappa or lambda) produced by plasma cell dyscrasias, such as multiple myeloma. The accumulation of these excess light chains leads to systemic organ damage. Beta-2 microglobulin is typically associated with dialysis-related amyloidosis, and SAA/TTR are associated with secondary forms.
Question 2 — Cardiology
An 85-year-old male presents with progressive heart failure symptoms, including pulmonary edema and peripheral edema. Physical examination reveals signs of low cardiac output, and the ECG shows marked bradycardia and conduction delays. The patient has no history of primary cardiac disease or chronic renal failure. Given his age and clinical presentation, which protein is most likely deposited in the myocardium?
- A) Serum Amyloid A (SAA)
- B) Alpha-synuclein
- C) Transthyretin (TTR)
- D) Beta-2 microglobulin
Answer: C. Senile systemic amyloidosis, or TTR amyloidosis, is a classic presentation in elderly males. The protein responsible for the deposition is transthyretin (TTR). This deposition causes restrictive cardiomyopathy and conduction abnormalities, leading to heart failure symptoms and bradycardia. Beta-2 microglobulin is associated with dialysis, and SAA/Alpha-synuclein are less specific or related to different pathologies.
Question 3 — Endocrinology
A 45-year-old patient with a history of poorly controlled Type 2 diabetes presents for routine follow-up. He has signs of metabolic syndrome and mild renal impairment. The physician suspects an underlying amyloidosis process. Which protein, derived from the metabolic derangement associated with insulin resistance, is most likely accumulating and forming amyloid deposits?
- A) Serum Amyloid A (SAA)
- B) Alpha-synuclein
- C) Amylin (IAPP)
- D) Light chains
Answer: C. In Type 2 diabetes, chronic hyperinsulinemia leads to the accumulation of amylin (islet amyloid polypeptide, IAPP). This protein is derived from proinsulin and forms amyloid deposits in various organs, including the pancreas (leading to islet cell damage), which is a common cause of type 3c diabetes.
Question 4 — Nephrology/Pathophysiology
A patient who has been undergoing long-term hemodialysis for chronic kidney disease presents with progressive symptoms suggestive of systemic amyloidosis, including cardiac conduction abnormalities and generalized edema. The primary mechanism leading to this condition is the inability of the dialysis circuit to effectively clear which specific protein?
- A) Serum Amyloid A (SAA)
- B) Beta-2 microglobulin ($\beta_2$-M)
- C) Transthyretin (TTR)
- D) Light chains
Answer: B. Dialysis-related amyloidosis is caused by the accumulation of $\beta_2$-microglobulin. Normally, the kidneys are responsible for excreting this protein; when kidney function declines and dialysis is required, the removal mechanism fails, leading to its deposition in various organs.
Quick fire review
What is the general definition of amyloidosis?
It is a condition caused by the misfolding and accumulation of proteins that deposit extracellularly in various organs.
What are the two main pathways leading to amyloid deposition?
1) Overproduction of a normal protein, or 2) Impaired clearance/removal of a protein.
What specific stain is used to identify amyloid deposits under polarized light microscopy?
Congo Red stain, which exhibits apple green birefringence.
Which type of amyloidosis is associated with multiple myeloma and involves monoclonal light chains?
Primary AL (light chain) amyloidosis.
In a patient with chronic inflammation (e.g., RA), what protein accumulates to cause secondary amyloidosis?
Serum Amyloid A (SAA).
What specific finding, combined with advanced age (>80 years), suggests senile systemic amyloidosis?
Heart failure symptoms and marked bradycardia/cardiac conduction issues.
Primary vs Secondary AL amyloidosis source?
Primary is associated with plasma cell dyscrasias (e.g., Multiple Myeloma, light chains). Secondary is associated with chronic inflammation (e.g., SAA from RA or infection).
What protein accumulates in patients undergoing long-term dialysis?
$\beta_2$-microglobulin.
What specific finding suggests TTR amyloidosis in an elderly male?
Heart failure symptoms and marked bradycardia, often diagnosed via Technetium-99m scintigraphy.
Which protein is responsible for the plaques seen in Down syndrome patients?
Amyloid precursor protein (due to Trisomy 21).
What are the three classic signs of amyloidosis related to Type 2 Diabetes?
Hypoglycemia, signs of hypoglycemia, and subsequent resolution/rebound glucose.
Name a prion disease associated with amyloid-like deposits in the brain.
Creutzfeldt-Jakob Disease (CJD), caused by $\text{PrP}^{Sc}$ protein.
Quick recall / Anki-style questions
Primary vs Secondary AL amyloidosis source?
Primary is associated with plasma cell dyscrasias (e.g., Multiple Myeloma, light chains). Secondary is associated with chronic inflammation (e.g., SAA from RA or infection).
What protein accumulates in patients undergoing long-term dialysis?
$\beta_2$-microglobulin.
What specific finding suggests TTR amyloidosis in an elderly male?
Heart failure symptoms and marked bradycardia, often diagnosed via Technetium-99m scintigraphy.
Which protein is responsible for the plaques seen in Down syndrome patients?
Amyloid precursor protein (due to Trisomy 21).
What are the three classic signs of amyloidosis related to Type 2 Diabetes?
Hypoglycemia, signs of hypoglycemia, and subsequent resolution/rebound glucose.
Name a prion disease associated with amyloid-like deposits in the brain.
Creutzfeldt-Jakob Disease (CJD), caused by $\text{PrP}^{Sc}$ protein.